Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 study

Authors: Agajanian, Richy, Ahmad, Rizvana, Aktas, Bahriye, Alencar, Victor Hugo, Amadori, Dino, Andrade, Jurandyr, André Franke, Fábio, Angiolini, Catia, Aogi, Kenjiro, Armor, Jess, Arpornwirat, Wichit, Assersohn, Laura, Audeh, William, Aulitzky, Walter, Azevedo, Sergio, Bartoli, Maria Alejandra, Batista Lopez, Norberto, Bianconi, María, Biganzoli, Laura, Birhiray, Ruemu, Bitina, Marianna, Blachy, Ron, Blackwell, Kimberly, Blanchard, Rita, Blanchet, Paulette, Boiangiu, Ion, Bower, Barbara, Brezden-Masley, Christine, Brufsky, Adam, Budde, Leanne, Caguioa, Priscilla, Calvo, Lourdes, Campone, Mario, Carroll, Robert R., Castro, Hugo, Chan, Valorie, Charu, Veena, Cinieri, Saverio, Clemens, Michael, Conejo, Emilio Alba, Côrtes, Eduardo, Coudert, Bruno, Cronemberger, Eduardo, Cubero, Daniel, Dakhil, Shaker, Daniel, Brooke, Davidson, Neville, De Fatima Gaui, Maria, De La Cruz, Susana, Del Pilar, Maria, Delgado, Gilson, Ellerton, John A., Estuardo, Cesar, Fehrenbacher, Louis, Ferrero, Jean-Marc, Flynn, Patrick J., Foszczynska-Kloda, Malgorzata, Franco, Sandra, Fujii, Hirofumi, Gallagher, Chris, Gamucci, Teresa, Giacomi, Nora, Gil I Gil, Miguel, Gonzalez Martin, Antonio, Gorbunova, Vera, Gotovkin, Eugeny, Green, Nathan, Grincuka, Elza, Grischke, Eva-Maria, Hansen, Vincent, Hargis, Jeffrey, Hauschild, Maik, Hegg, Roberto, Hendricks, Carolyn, Hermann, Robert, Hoff, Paulo, Horiguchi, Jun, Hornedo Muguiro, Javier, Iacobelli, Stefano, Inoue, Kenichi, Ismael, Gustavo, Itoh, Yoshinori, Iwata, Dr Hiroji, Jendiroba, Davi, Jochim, Rosa, Jones, Alison, Just, Marianne, Kallab, Andre, Karwal, Mark, Kashiwaba, Masahiro, Kato, Giraldo, Kaufman, Peter A., Kellokumpu-Lehtinen, Pirkko, Kirsch, Andreas, Kiselev, Igor, Klein, Paula, Kohno, Norio, Kopp, Mikhail, Kostovska-Maneva, Liljana, Kotliar, Mauricio, Kudaba, Iveta, Kümmel, Sherko, Kuroi, Katsumasa, Lacava, Juan, Latini, Luciano, Lee, Soo Chin, Lichinitser, Mikhail, Lobo, Christopher, Maintz, Christoph, Maneecahvakajorn, Jedzada, Marmé, Alexander, Martinez, Gloria, Masuda, Norikazu, Matwiejuk, Mario, Merculov, Vladimir, Michaelson, Richard, Miguel, Luis, Monroy, Hernandez, Montemurro, Filippo, Morales, Serafin, Moura, Rodrigo, Mueller, Volkmar, Mulatero, Clive, Nakagami, Kazuhiko, Nakayama, Takahiro, Neidhart, Jeff, Nguyen, An, Nishimura, Reiki, Ogata, Haruki, O'reilly, Susan, O'rourke, Timothy, Otero Reye, Douglas, Ouyang, Xuenong, Patel, Ravi, Patel, Taral, Pedrini, Jose Luiz, Pereira, Rodrigo, Perez, Alejandra, Peterson, Carol, Pienkowski, Tadeusz, Pinczowski, Helio, Polikoff, Jonathan, Polkowski, Wojciech, Price, Paola Edith, Prill, Sue, Priou, Frank, Purkalne, Gunta, Pyrhoenen, Seppo, Quackenbush, Robert, Rai, Yoshiaki, Ribelles, Nuria, Ro, Jungsil, Robinson, Anne, Robles, Robert, Rodriguez, Gladys, Roman, Laslo, Saji, Shigehira, Sanchez-Rovira, Pedro, Sato, Nobuaki, Schmidt, Marcus, Schumacher, Claudia, Senecal, Frank, Sharma, Priyanka, Shen, Zhenzhou, Shirinkin, Vadim, Simoncini, Edda, Sirisinha, Thitiya, Smith, Raymond, Sohn, Joo-Hyuk, Soldic, Zeljko, Soria, Tania, Spicer, Darcy, Srimuninnimit, Vichien, Sriuranpong, Virote, Staroslawska, Elzbieta, Stefanovski, Petar, Sunpaweravong, Patrapim, Taguchi, Julie, Takeda, Koji, Tellez-Trevilla, Gabriel, Thomas, Randall, Thomssen, Christoph, Toache, Zetina, Tokuda, Yutaka, Tomczak, Piotr, Tosello, Celia, Tsugawa, Koichiro, Tudtud, Dennis, Ueno, Takayuki, Van Eyll, Brigitte, Varela, Mirta, Vasev, Nikola, Vrbanec, Damir, Wang, Xiaojia, Wang, Liwei, Watanabe, Junichiro, Waterhouse, David, Wesenberg, Birgitta, Wheatley, Duncan, Wong, Zee Wan, Yadav, Sanjay, Yardley, Denise, Yau, Tsz-Kok, Yeo, Winnie, Ying, Cheng, Youn Oh, Do, Swain, Sandra M ^*, Miles, David, Kim, Sung-Bae, Im, Young-Hyuck, Im, Seock-Ah, Semiglazov, Vladimir, Ciruelos, Eva, Schneeweiss, Andreas, Loi, Sherene, Monturus, Estefanía, Clark, Emma, Knott, Adam, Restuccia, Eleonora, Benyunes, Mark C, Cortés, Javier

Source: In The Lancet Oncology April 2020 21(4):519-530

A randomised phase II study of chemoradiotherapy with or without nimotuzumab in locally advanced oesophageal cancer: NICE trial

Authors: de Castro Junior, Gilberto, Segalla, José Getúlio, de Azevedo, Sérgio Jobim, Andrade, Carlos José, Grabarz, Daniel, de Araújo Lima França, Bruno, Del Giglio, Auro, Lazaretti, Nicolas Silva, Álvares, Maria Nunes, Pedrini, José Luiz, Kussumoto, Celio, de Matos Neto, João Nunes, Forones, Nora Manoukian, Fernandes Júnior, Hezio Jadir, Borges, Giuliano, Girotto, Gustavo, da Silva, Ismael Dale Cotrim Guerreiro, Maluf-Filho, Fauze, Skare, Nils Gunnar

Source: In European Journal of Cancer January 2018 88:21-30

5-year analysis of neoadjuvant pertuzumab and trastuzumab in patients with locally advanced, inflammatory, or early-stage HER2-positive breast cancer (NeoSphere): a multicentre, open-label, phase 2 randomised trial

Authors: Gianni, Luca, Pienkowski, Tadeusz, Im, Young-Hyuck, Tseng, Ling-Ming, Liu, Mei-Ching, Lluch, Ana, Starosławska, Elżbieta, de la Haba-Rodriguez, Juan, Im, Seock-Ah, Pedrini, Jose Luiz, Poirier, Brigitte, Morandi, Paolo, Semiglazov, Vladimir, Srimuninnimit, Vichien, Bianchi, Giulia Valeria, Magazzù, Domenico, McNally, Virginia, Douthwaite, Hannah, Ross, Graham, Valagussa, Pinuccia

Source: In The Lancet Oncology June 2016 17(6):791-800

A phase III, randomized, non-inferiority study comparing the efficacy and safety of biosimilar filgrastim versus originator filgrastim for chemotherapy-induced neutropenia in breast cancer patients

Authors: Hegg, Roberto ^*, Mattar, André, de Matos, João Nunes, Neto, Pedrini, José Luiz, Aleixo, Sabina Bandeira, Rocha, Roberto Odebrecht, Cramer, Renato Peixoto, Junior, van-Eyll-Rocha, Sylvie

Source: In Clinics 2016 71(10):586-592

Efficacy and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early HER2-positive breast cancer (NeoSphere): a randomised multicentre, open-label, phase 2 trial

Authors: Gianni, Luca, Pienkowski, Tadeusz, Im, Young-Hyuck, Roman, Laslo, Tseng, Ling-Ming, Liu, Mei-Ching, Lluch, Ana, Staroslawska, Elżbieta, de la Haba-Rodriguez, Juan, Im, Seock-Ah, Pedrini, Jose Luiz, Poirier, Brigitte, Morandi, Paolo, Semiglazov, Vladimir, Srimuninnimit, Vichien, Bianchi, Giulia, Szado, Tania, Ratnayake, Jayantha, Ross, Graham, Valagussa, Pinuccia

Source: In Lancet Oncology 2012 13(1):25-32

Treatment with trastuzumab for 1 year after adjuvant chemotherapy in patients with HER2-positive early breast cancer: a 4-year follow-up of a randomised controlled trial

Authors: Gianni, Luca, Dafni, Urania, Gelber, Richard D, Azambuja, Evandro, Muehlbauer, Susanne, Goldhirsch, Aron, Untch, Michael, Smith, Ian, Baselga, José, Jackisch, Christian, Cameron, David, Mano, Max, Pedrini, José Luiz, Veronesi, Andrea, Mendiola, Cesar, Pluzanska, Anna, Semiglazov, Vladimir, Vrdoljak, Eduard, Eckart, Michael J, Shen, Zhenzhou, Skiadopoulos, George, Procter, Marion, Pritchard, Kathleen I, Piccart-Gebhart, Martine J, Bell, Richard

Source: In Lancet Oncology 2011 12(3):236-244

Management of early-stage triple-negative breast cancer: recommendations of a panel of experts from the Brazilian Society of Mastology.

Authors: Freitas-Junior, Ruffo, de Oliveira, Vilmar Marques, Frasson, Antonio Luiz, Cavalcante, Francisco Pimentel, Mansani, Fabio Postiglione, Mattar, André, Zerwes, Felipe Pereira, de Oliveira Freitas, Adriana Magalhães, de Souza, Alessandra Borba Anton, Damin, Andrea P., dos Santos, Annamaria Massahud Rodrigues, Ruiz, Carlos Alberto, de Lucena, Clécio Ênio Murta, Millen, Eduardo Camargo, Bagnoli, Fábio, Andrade, Felipe, Rodrigues, Frank Lane Braga, Facina, Gil, Novita, Guilherme, Pedrini, Jose Luiz

Source: BMC Cancer; 11/23/2022, Vol. 22 Issue 1, p1-12, 12p

Subject Terms: TRIPLE-negative breast cancer, SENTINEL lymph node biopsy, NEOADJUVANT chemotherapy, BREAST cancer, CANCER treatment

Expression of alpha 1 and beta 3 integrins subunits in the endometrium of patients with tubal phimosis or hydrosalpinx

Authors: Savaris, Ricardo Francalacci, Pedrini, José Luiz, Flores, Renato, Fabris, Gemir, Zettler, Cláudio Galleano

Source: In Fertility and Sterility 2006 85(1):188-192

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

Expressão da cox-2 e CD105 no câncer de mama e sobrevida livre de doença

Authors: Grudzinski, Melina, Cambruzzi, Eduardo, Lahude, Eduardo, Savaris, Ricardo Francalacci, Pedrini, José Luiz, Zettler, Cláudio Galleano

Source: Revista da Associação Médica Brasileira. August 2006 52(4)

Subject Terms: Câncer de mama, Ciclooxigenase 2, CD105

File Description: text/html

Access URL: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302006000400031

This result is not displayed to guests.
Login for full access.

Estudo comparativo da presença dos fatores prognósticos Receptor de Estrogênio, cerbb-2, p53 e e-caderina no câncer primário da mama e sua recidiva local

Authors: Pedrini, José Luiz

Source: Revista Brasileira de Ginecologia e Obstetrícia. August 2002 24(7)

File Description: text/html

Access URL: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-72032002000700013